Similar Articles
521 Cellular based treatment modalities for unresectable hepatocellular carcinoma
522 Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
523 Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
524 Skeletal muscle metastases of hepatocellular carcinoma: A case report and literature review
525 Biomarkers for hepatocellular carcinoma based on body fluids and feces
526 Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
527 Radiofrequency ablation vs surgical resection in elderly patients with hepatocellular carcinoma in Milan criteria
528 Prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm based on computed tomography radiomics
529 Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
530 Clinical value of artificial intelligence in hepatocellular carcinoma: Current status and prospect
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA